These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 27079868)
21. Resistance after chronic application of the HDAC-inhibitor valproic acid is associated with elevated Akt activation in renal cell carcinoma in vivo. Juengel E; Makarević J; Tsaur I; Bartsch G; Nelson K; Haferkamp A; Blaheta RA PLoS One; 2013; 8(1):e53100. PubMed ID: 23372654 [TBL] [Abstract][Full Text] [Related]
22. Butanol fraction of Khaya senegalensis root modulates β-cell function and ameliorates diabetes-related biochemical parameters in a type 2 diabetes rat model. Ibrahim MA; Islam MS J Ethnopharmacol; 2014 Jul; 154(3):832-8. PubMed ID: 24846204 [TBL] [Abstract][Full Text] [Related]
23. Novel Pentapeptide GLP-1 (32-36) Amide Inhibits β-Cell Apoptosis In Vitro and Improves Glucose Disposal in Streptozotocin-Induced Diabetic Mice. Sun L; Dai Y; Wang C; Chu Y; Su X; Yang J; Zhou J; Huang W; Qian H Chem Biol Drug Des; 2015 Dec; 86(6):1482-90. PubMed ID: 26178446 [TBL] [Abstract][Full Text] [Related]
24. Effects and underlying mechanisms of irisin on the proliferation and apoptosis of pancreatic β cells. Liu S; Du F; Li X; Wang M; Duan R; Zhang J; Wu Y; Zhang Q PLoS One; 2017; 12(4):e0175498. PubMed ID: 28394923 [TBL] [Abstract][Full Text] [Related]
25. Early Treatment with Empagliflozin and GABA Improves Daems C; Welsch S; Boughaleb H; Vanderroost J; Robert A; Sokal E; Lysy PA J Diabetes Res; 2019; 2019():2813489. PubMed ID: 31467926 [TBL] [Abstract][Full Text] [Related]
26. Proposed mechanisms for oligonucleotide IMT504 induced diabetes reversion in a mouse model of immunodependent diabetes. Bianchi MS; Bianchi S; Hernado-Insúa A; Martinez LM; Lago N; Libertun C; Chasseing NA; Montaner AD; Lux-Lantos VA Am J Physiol Endocrinol Metab; 2016 Aug; 311(2):E380-95. PubMed ID: 27329801 [TBL] [Abstract][Full Text] [Related]
27. Effect of Silymarin in Pdx-1 expression and the proliferation of pancreatic β-cells in a pancreatectomy model. Soto C; Raya L; Juárez J; Pérez J; González I Phytomedicine; 2014 Feb; 21(3):233-9. PubMed ID: 24176839 [TBL] [Abstract][Full Text] [Related]
28. A novel long acting DPP-IV inhibitor PKF-275-055 stimulates β-cell proliferation resulting in improved glucose homeostasis in diabetic rats. Akarte AS; Srinivasan BP; Gandhi S Biochem Pharmacol; 2012 Jan; 83(2):241-52. PubMed ID: 22015634 [TBL] [Abstract][Full Text] [Related]
29. Histone deacetylase 8 suppresses osteogenic differentiation of bone marrow stromal cells by inhibiting histone H3K9 acetylation and RUNX2 activity. Fu Y; Zhang P; Ge J; Cheng J; Dong W; Yuan H; Du Y; Yang M; Sun R; Jiang H Int J Biochem Cell Biol; 2014 Sep; 54():68-77. PubMed ID: 25019367 [TBL] [Abstract][Full Text] [Related]
30. Repression of Transcriptional Activity of Forkhead Box O1 by Histone Deacetylase Inhibitors Ameliorates Hyperglycemia in Type 2 Diabetic Rats. Cho HM; Seok YM; Lee HA; Song M; Kim I Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30424007 [TBL] [Abstract][Full Text] [Related]
31. HDAC inhibition through valproic acid modulates the methylation profiles in human embryonic kidney cells. Ganai SA; Kalladi SM; Mahadevan V J Biomol Struct Dyn; 2015; 33(6):1185-97. PubMed ID: 25012937 [TBL] [Abstract][Full Text] [Related]
32. Valproic acid induces NET cell growth arrest and enhances tumor suppression of the receptor-targeted peptide-drug conjugate via activating somatostatin receptor type II. Sun L; Qian Q; Sun G; Mackey LV; Fuselier JA; Coy DH; Yu CY J Drug Target; 2016; 24(2):169-77. PubMed ID: 26211366 [TBL] [Abstract][Full Text] [Related]
33. Valproic acid-mediated neuroprotection in retinal ischemia injury via histone deacetylase inhibition and transcriptional activation. Zhang Z; Qin X; Tong N; Zhao X; Gong Y; Shi Y; Wu X Exp Eye Res; 2012 Jan; 94(1):98-108. PubMed ID: 22143029 [TBL] [Abstract][Full Text] [Related]
34. Teratogenic effects mediated by inhibition of histone deacetylases: evidence from quantitative structure activity relationships of 20 valproic acid derivatives. Eikel D; Lampen A; Nau H Chem Res Toxicol; 2006 Feb; 19(2):272-8. PubMed ID: 16485903 [TBL] [Abstract][Full Text] [Related]
35. Biochemical efficacy of vitamin D in ameliorating endocrine and metabolic disorders in diabetic rats. Sadek KM; Shaheen H Pharm Biol; 2014 May; 52(5):591-6. PubMed ID: 24251869 [TBL] [Abstract][Full Text] [Related]
36. Hidden pharmacological activities of valproic acid: A new insight. Singh D; Gupta S; Verma I; Morsy MA; Nair AB; Ahmed AF Biomed Pharmacother; 2021 Oct; 142():112021. PubMed ID: 34463268 [TBL] [Abstract][Full Text] [Related]
37. Targeting of histone deacetylases to reactivate tumour suppressor genes and its therapeutic potential in a human cervical cancer xenograft model. Feng D; Wu J; Tian Y; Zhou H; Zhou Y; Hu W; Zhao W; Wei H; Ling B; Ma C PLoS One; 2013; 8(11):e80657. PubMed ID: 24260446 [TBL] [Abstract][Full Text] [Related]
38. Anti-diabetic effects of Centratherum anthelminticum seeds methanolic fraction on pancreatic cells, β-TC6 and its alleviating role in type 2 diabetic rats. Arya A; Looi CY; Cheah SC; Mustafa MR; Mohd MA J Ethnopharmacol; 2012 Oct; 144(1):22-32. PubMed ID: 22954496 [TBL] [Abstract][Full Text] [Related]
39. A bio-inspired injectable hydrogel as a cell platform for real-time glycaemic regulation. Zhang Y; Yang J; Zhang J; Li S; Zheng L; Zhang Y; Meng H; Zhang X; Wu Z J Mater Chem B; 2020 Jun; 8(21):4627-4641. PubMed ID: 32373901 [TBL] [Abstract][Full Text] [Related]